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Alcoholism is estimated to cost the
United States a quarter of a trillion dollars
annually, including the deaths of 88,000
individuals. Recovering alcoholics often
experience a multitude of withdrawal
symptoms including long-term mood
disturbances. Clinical studies have reported
a strong relationship between anxiety and
alcohol relapse, which hinders long-term
recovery (Hershon, 1977; Cloninger, 1987;
De Soto et al., 1989; Annis et al., 1998).
Corticotropin-releasing factor (CRF) is a
42-amino acid neuropeptide that regulates
the mammalian endocrine, autonomic,
and behavioral stress responses. Due to
the relationship between anxiety and
alcohol relapse, the CRF system is also an
important mediator in enhanced alcohol
self-administration and anxiety-related
behaviors during acute and prolonged
alcohol withdrawal. Research has shown
that CRF2 receptor activation alleviates
anxiety-related behaviors during acute
withdrawal. Due to the long-term mood
alterations caused by alcohol withdrawal,
this study explored the effects of CRF2
receptor activation on anxiety-related
behaviors during prolonged alcohol
withdrawal. We hypothesized that the
activation of CRF2 receptors would
decrease anxiety-related behaviors following
protracted periods of alcohol withdrawal.
Male and female Wistar rats (n=16) were
exclusively fed a liquid diet composed
of 10% alcohol or sugar as an isocaloric
control -for 25 days with unlimited access.
Twenty-four hours after the removal of the
ethanol liquid diet, rats were examined for
signs of physical withdrawal. Afterward,
rats were left undisturbed except for
routine husbandry for 5 weeks prior to
testing on the elevated plus maze, an
animal model of anxiety. Ten minutes
prior to testing, all rodents where given
either 10 µg of the CRF2 receptor agonist
Urocortin 3 (Ucn3) or vehicle only
(control). Rodents were placed on the
elevated plus maze for 5 minutes. Every
entry and time spent onto each arm of
the elevated plus maze were recorded for
5 minutes as measures of general motor
activity and anxiety-like behavior.
The results did support our hypothesis.
No differences were found in body weight
and fluid intake between all groups during
liquid diet administration. A two-tail t-test
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confirmed that ethanol liquid diet fed rats
experienced significantly more withdrawal
signs compared to controls demonstrating
that they were alcohol dependent. A
two-way ANOVA was used to analyze
behavior in the elevated plus maze with
ethanol liquid diet condition and Ucn
3 dose and between-subjects factors. A
significant interaction between the ethanol
liquid diet and Ucn 3 was found. Alcohol
dependent rats that were given Ucn3 prior
to testing spent more time on the open
arms of the maze compared to those that
only received vehicle. This indicates CRF2
activation alleviates anxiety-like behaviors
in rats experiencing prolonged alcohol
withdrawal. No differences were found in
the number of closed arm entries between
groups, suggesting that differences are likely
not due to general motor impairment.
Limitations of this study involve a low
number of subjects. Future research will
benefit from larger sample sizes to better
indicate external validity. Other animal
models of anxiety should also be used to
confirm that CRF2 activation can alleviate
anxiety-like behaviors in a multitude
of scenarios. If our initial results are
supported, this could be an incentive for
pharmaceutical companies to invest in the
development of therapeutic medications
for recovering alcoholics by targeting CRF2
receptors to prevent anxiety related relapse.
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